NPS Allelix Corp.

PROFILE NPS Allelix is in the elixir biz. Formerly Allelix Biopharmaceuticals, the company is now a subsidiary of NPS Pharmaceuticals. It develops two major types of drugs: protein-based drugs (for osteoporosis and digestive disorders) and neuropharmaceuticals (for central nervous system disorders such as migraine headaches). ALX1-11, the company's flagship product, is in Phase III clinical trials as a treatment for postmenopausal osteoporosis. The company has development alliances with Eli Lilly and Johnson & Johnson subsidiary Janssen Pharmaceutica. It also has a development and marketing agreement with Forest Laboratories for ALX-0646, its treatment for migraine headaches.		FINANCIAL OVERVIEW Fiscal Year-End: August 1998 Sales (mil.): 19.10 1-Yr. Sales Growth: 75.5% Employees: 168 Revenue per employee: $113,690.48  KEY PEOPLE • Hunter Jackson     CEO • Robert K. Merrell     CFO  CONTACT INFO 6850 Goreway Dr. Mississauga Ontario L4V 1V7, Canada Phone: 1-905-677-0831 Fax: 1-905-677-9595 Online: Web Site

	Company Data   News, quotes & more

		Hoover's Company Capsule Copyright © 2001, Hoover's Inc. Austin, Texas. For changes and updates, contact Hoover's directly.